Publisher: Research Institute for Gastroenterology and Liver Diseases (RIGLD)
  • Register
  • Login

Gastroenterology and Hepatology from Bed to Bench

  • Home
  • Issues
    • Current
    • Archives
  • About
    • About the Journal
    • Aims and Scope
    • Editorial Team
    • Privacy Statement
    • Contact
  • For Authors
    • Submissions
    • Author Guidelines
    • Article Processing Charge
    • Peer Review Process
  • Indexing & Abstracting
  • Announcements
Advanced Search
  1. Home
  2. Archives
  3. Vol. 16 No. 1 (2023): Vol 16, No 1 (2023): Winter
  4. Original Article

Vol. 16 No. 1 (2023)

January 2023

The SW480 cell line, overexpressing PIWIL2 gene, maintains the expression of stemness and proliferation genes in the mice xenografts

  • Roya Kishani Farahani
  • Ehsan Nazemalhosseini Mojarad
  • Hamid Reza Soleimanpour-lichaei

Gastroenterology and Hepatology from Bed to Bench, Vol. 16 No. 1 (2023), 2 January 2023
https://doi.org/10.22037/ghfbb.v16i1.2661 Published: 2022-12-31

  • View Article
  • Download
  • Cite
  • References
  • Statastics
  • Share

Abstract

Aim: This study aims to confirm previous fundamental in vitro findings about the PIWIL2 gene by investigating the effects of its overexpression on cell cycle, proliferation, apoptosis, and stem cell expression markers in colorectal cancer cells (CRC cells) at in vivo level.

Background: PIWIL2 has a critical role in maintaining cellular stemness and proliferation. PIWIL2 is an oncogene whose expression in CRC is associated with the occurrence, metastasis, and poor prognosis.

Methods: SW480 cells harboring expression vectors with/without PIWIL2 were cultured and inoculated in BALB/c nude mice. Tumor formation and growth were monitored every 3 days. On the 28th day after inoculation, the tumors were harvested for their total RNA extraction, and the expression profiling of the candidate genes was performed by Real-time PCR.

Results: Our results for the expression profiling of the xenografted tumors showed a significant increase in the expression of cancer stem cell markers, including CD24, CD133, and pluripotency marker SOX2 in the PIWIL2 over-expressing xenografts, compared to the control cell line. Moreover, PIWIL2 dramatically promoted the anti-apoptotic pathway by inducing STAT3 and BCL2-L1 genes in the PIWIL2 over-expressing xenografts, along with the up-regulation of Cyclin D1 and Ki-67 genes.

Conclusion: This research supports our prior in vitro findings, highlighting the critical role that PIWIL2 plays in the development of CRC and its substantial promise as a leading candidate for CRC-targeted therapy. 

Keywords:
  • PIWIL2, colorectal cancer, stemness, proliferation, apoptosis
  • PDF

How to Cite

Kishani Farahani, R., Nazemalhosseini Mojarad, E. ., & Soleimanpour-lichaei, H. R. . (2022). The SW480 cell line, overexpressing PIWIL2 gene, maintains the expression of stemness and proliferation genes in the mice xenografts. Gastroenterology and Hepatology from Bed to Bench, 16(1). https://doi.org/10.22037/ghfbb.v16i1.2661
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver
  • Endnote/Zotero/Mendeley (RIS)
  • BibTeX

References

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71:209-249.

Pretzsch E, Bösch F, Neumann J, Ganschow P, Bazhin A, Guba M, et al. Mechanisms of metastasis in colorectal cancer and metastatic organotropism: hematogenous versus peritoneal spread. J Oncol 2019;2019.

Fahmi MN, Hertapanndika IN, Kusuma F. The prognostic value of cancer stem cell markers in cervical cancer: a systematic review and meta-analysis. Asian Pac J Cancer Prev 2021;22:4057-4065.

Ren F, Sheng WQ, Du X. CD133: a cancer stem cells marker, is used in colorectal cancers. World J Gastroenterol 2013;19:2603-2611.

Iinuma H, Watanabe T, Mimori K, Adachi M, Hayashi N, Tamura J, et al. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer. J Clin Oncol 2011;29:1547-1555.

Jao SW, Chen SF, Lin YS, Chang YC, Lee TY, Wu CC, et al. Cytoplasmic CD133 expression is a reliable prognostic indicator of tumor regression after neoadjuvant concurrent chemoradiotherapy in patients with rectal cancer. Ann Surg Oncol 2012;19:3432-3440.

Panagiotou E, Syrigos NK, Charpidou A, Kotteas E, Vathiotis IA. CD24: a novel target for cancer immunotherapy. J Pers Med 2022;12:1235.

Haddock S, Alban TJ, Turcan Ş, Husic H, Rosiek E, Ma X, et al. Phenotypic and molecular states of IDH1 mutation-induced CD24-positive glioma stem-like cells. Neoplasia 2022;28:100790.

Belov L, Zhou J, Christopherson RI. Cell surface markers in colorectal cancer prognosis. Int J Mol Sci 2010;12:78-113.

Lee J-H, Kim S-H, Lee E-S, Kim Y-S. CD24 overexpression in cancer development and progression: a meta-analysis. Oncol Rep 2009;22:1149-1156.

Walcher L, Kistenmacher A-K, Suo H, Kitte R, Dluczek S, Strauß A, et al. Cancer stem cells-origins and biomarkers: perspectives for targeted personalized therapies. Front Immunol 2020;11:1280.

Ramesh P, Medema JP. BCL-2 family deregulation in colorectal cancer: potential for BH3 mimetics in therapy. Apoptosis 2020;25:305-320.

Gargalionis AN, Papavassiliou KA, Papavassiliou AG. Targeting STAT3 signaling pathway in colorectal cancer. Biomedicines 2021;9:1016.

Jin-Song Y, Zhao-Xia W, Cheng-Yu L, Xiao-Di L, Ming S, Yuan-Yuan G, et al. Prognostic significance of Bcl-xL gene expression in human colorectal cancer. Acta Histochem. 2011;113:810-814.

Han HS, Park YM, Hwang TS. Differential expression of Bcl‐2, Bcl‐XL and p53 in colorectal cancer. J Gastroenterol Hepatol 2006;21:1108-1114.

Li W, Ma Y, He L, Li H, Chu Y, Jiang Z, et al. Protease-activated receptor 2 stabilizes Bcl-xL and regulates EGFR–targeted therapy response in colorectal cancer. Cancer Lett 2021;517:14-23.

Alao JP. The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention. Mol Cancer 2007;6:1-16.

Lee JH, Schütte D, Wulf G, Füzesi L, Radzun H-J, Schweyer S, et al. Stem-cell protein Piwil2 is widely expressed in tumors and inhibits apoptosis through activation of Stat3/Bcl-XL pathway. Hum Mol Genet 2006;15:201-211.

Li J, Xu L, Bao Z, Xu P, Chang H, Wu J, et al. High expression of PIWIL2 promotes tumor cell proliferation, migration and predicts a poor prognosis in glioma. Oncol Rep 2017;38:183-192.

Sasaki T, Shiohama A, Minoshima S, Shimizu N. Identification of eight members of the Argonaute family in the human genome☆. Genomics 2003;82:323-330.

Kuramochi-Miyagawa S, Kimura T, Yomogida K, Kuroiwa A, Tadokoro Y, Fujita Y, et al. Two mouse piwi-related genes: miwi and mili. Mech Dev 2001;108:121-133.

Cox DN, Chao A, Lin H. Piwi encodes a nucleoplasmic factor whose activity modulates the number and division rate of germline stem cells. Development 2000;127:503-514.

Chen L, Shen R, Ye Y, Pu X-A, Liu X, Duan W, et al. Precancerous stem cells have the potential for both benign and malignant differentiation. PloS one 2007;2:293.

Kishani-Farahani R, Soleimanpour S, Golmohammadi M, Soleimanpour-lichaei H. PIWIL2 regulates the proliferation, apoptosis and colony formation of colorectal cancer cell line. Iran J Biotechnol. in press.

Akbari M, Shomali N, Faraji A, Shanehbandi D, Asadi M, Mokhtarzadeh A, et al. CD133: an emerging prognostic factor and therapeutic target in colorectal cancer. Cell Biol Int 2020;44:368-380.

Sun X, Kaufman PD. Ki-67: more than a proliferation marker. Chromosoma 2018;127:175-186.

Richardsen E, Andersen S, Al-Saad S, Rakaee M, Nordby Y, Pedersen MI, et al. Evaluation of the proliferation marker Ki-67 in a large prostatectomy cohort. PloS one 2017;12:0186852.

Oh S-J, Kim S-M, Kim Y-O, Chang H-K. Clinicopathologic implications of PIWIL2 expression in colorectal cancer. J Pathol Transl Med 2012;46:318-323.

Li D, Sun X, Yan D, Huang J, Luo Q, Tang H, et al. Piwil2 modulates the proliferation and metastasis of colon cancer via regulation of matrix metallopeptidase 9 transcriptional activity. Exp Biol Med 2012;237:1231-1240.

Shahali M, Kabir-Salmani M, Nayernia K, Soleimanpour-Lichaei HR, Vasei M, Mowla SJ, et al. A novel in vitro model for cancer stem cell culture using ectopically expressed piwil2 stable cell line. Cell J (Yakhteh) 2013;15:250.

Zhang D, Wu X, Liu X, Cai C, Zeng G, Rohozinski J, et al. Piwil2-transfected human fibroblasts are cancer stem cell-like and genetically unstable. Oncotarget 2017;8:12259.

Liu JJ, Shen R, Chen L, Ye Y, He G, Hua K, et al. Piwil2 is expressed in various stages of breast cancers and has the potential to be used as a novel biomarker. Int J Clin Exp Pathol 2010;3:328.

Qu X, Liu J, Zhong X, Li X, Zhang Q. PIWIL2 promotes progression of non-small cell lung cancer by inducing CDK2 and Cyclin A expression. J Transl Med 2015;13:1-10.

Katayose Y, Kim M, Rakkar AN, Li Z, Cowan KH, Seth P. Promoting apoptosis: a novel activity associated with the cyclin-dependent kinase inhibitor p27. Cancer Res 1997;57:5441-5445.

Lee JH, Jung C, Javadian-Elyaderani P, Schweyer S, Schütte D, Shoukier M, et al. Pathways of proliferation and antiapoptosis driven in breast cancer stem cells by stem cell protein Piwil2 in breast cancer stem cells. Cancer Res 2010;70:4569-4579.

  • Abstract Viewed: 343 times
  • PDF Downloaded: 226 times

Download Statastics

  • Linkedin
  • Twitter
  • Facebook
  • Google Plus
  • Telegram

Developed By

Open Journal Systems
  • Home
  • Archives
  • Submissions
  • About the Journal
  • Editorial Team
  • Contact

GHFBB journal is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0).

Print ISSN: 2008-2258
Online ISSN: 2008-4234

Support Contact: ghfbb.journal@gmail.com

Powered by OJSPlus